ENDRA Life Sciences Inc. (NDRA)
4.05
-0.20 (-4.71%)
At close: Mar 28, 2025, 3:59 PM
4.16
2.75%
After-hours: Mar 28, 2025, 05:00 PM EDT
ENDRA Life Sciences Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Revenue | n/a | n/a | n/a | n/a | n/a | 6.17K | 351.62K | 515.58K | 1.41M | 559.36K |
| Cost of Revenue | 275.45K | 234.26K | 224.41K | 165.25K | 115.01K | n/a | 172.78K | 235.88K | 666.23K | 259.14K |
| Gross Profit | -275.45K | -234.26K | -224.41K | -165.25K | -115.01K | 6.17K | 178.84K | 279.7K | 743.83K | 300.21K |
| Operating Income | -10.52M | -13.16M | -11.5M | -11.5M | -10.84M | -9.02M | -4.63M | -1.79M | -1.57M | -1.53M |
| Interest Income | n/a | n/a | n/a | 232.43 | 2.36K | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -10.06M | -13.18M | -11.23M | -11.73M | -13.31M | -9.8M | -5.38M | -2.78M | -2.28M | -2.18M |
| Net Income | -10.06M | -13.2M | -11.19M | -11.97M | -15.55M | -9.8M | -5.38M | -2.78M | -2.28M | -2.18M |
| Selling & General & Admin | 5.52M | 6.6M | 6.02M | 5.58M | 4.27M | 4.02M | 2.87M | 1.58M | 1.27M | 953.22K |
| Research & Development | 5M | 6.55M | 5.48M | 5.92M | 6.57M | 4.72M | 1.93M | 495.38K | 1.04M | 873.17K |
| Other Expenses | n/a | -21.53K | -41.55K | 8.84K | -106.9K | -777.25K | n/a | -5.82K | -711.34K | n/a |
| Operating Expenses | 10.52M | 13.16M | 11.5M | 11.5M | 10.84M | 8.74M | 4.8M | 2.07M | 2.31M | 1.83M |
| Interest Expense | n/a | 21.53K | n/a | 232.43K | 2.36M | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | 820.55K | 1.43M | 1.08M | 581.89K | 412.43K | 262.64K | 122.6K | 34.13K | 50.63K | 56.3K |
| Cost & Expenses | 10.52M | 13.16M | 11.5M | 11.5M | 10.84M | 8.74M | 4.98M | 2.31M | 2.98M | 2.09M |
| Income Tax | n/a | 21.53K | -41.55K | 241.27K | 2.25M | -777.25K | 750.9K | 983.61K | 710.63K | 654.7K |
| Shares Outstanding (Basic) | 9.04M | 2.89M | 2.05M | 959.61K | 375K | 225.24K | 137.85K | 195.35K | 195.35K | 195.35K |
| Shares Outstanding (Diluted) | 9.04M | 2.89M | 2.05M | 959.61K | 375K | 225.24K | 195.75K | 195.35K | 195.35K | 30.63K |
| EPS (Basic) | -1.11 | -4.57 | -5.47 | -12.47 | -41.48 | -43.49 | -39.01 | -14.21 | -11.67 | -11.16 |
| EPS (Diluted) | -1.11 | -4.57 | -5.47 | -12.47 | -41.48 | -43.49 | -39.01 | -14.21 | -11.67 | -11.16 |
| EBITDA | -9.78M | -12.94M | -11.01M | -11.33M | -10.84M | -9.02M | -4.56M | -1.73M | -1.5M | -1.49M |
| Depreciation & Amortization | 275.45K | 234.26K | 224.41K | 165.25K | 115.01K | 68.32K | 61.48K | 64.94K | 72.22K | 37.24K |